January 30, 2015

Prezcobix and Evotaz: Two New HIV Fixed Dose Combinations Approved this Week

January 29, 2015 Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced the U.S. Food and Drug Administration (FDA) has approved PREZCOBIX™ (darunavir 800 mg/cobicistat […]